LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 84 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -66.7% | 60 | -83.3% | 0.00% | -100.0% |
| Q4 2016 | $6,000 | +100.0% | 360 | +200.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | +50.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | -33.3% | 120 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $3,000 | 0.0% | 120 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,000 | -72.7% | 120 | -80.6% | 0.00% | -66.7% |
| Q1 2015 | $11,000 | +450.0% | 620 | +416.7% | 0.00% | – |
| Q4 2014 | $2,000 | -50.0% | 120 | -68.4% | 0.00% | -100.0% |
| Q3 2014 | $4,000 | -42.9% | 380 | -49.5% | 0.00% | 0.0% |
| Q2 2014 | $7,000 | -50.0% | 753 | -43.8% | 0.00% | -66.7% |
| Q1 2014 | $14,000 | – | 1,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |